NO170480C - Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater

Info

Publication number: NO170480C
Authority: NO; Norway
Prior art keywords: phenoyxydicoic; preparation; acid derivatives; therapeutic active; analogy procedure
Prior art date: 1985-07-30

Application number

NO863061A

Other languages

English (en)

Norwegian (no)

Other versions

NO863061L (no

NO170480B (no

NO863061D0 (no

Inventor

Brian Roy Holloway

Ralph Howe

Balbir Singh Rao

Donald Stribling

Original Assignee

Ici Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-07-30

Filing date

1986-07-29

Publication date

1992-10-21

1986-07-29 Application filed by Ici Plc filed Critical Ici Plc

1986-07-29 Publication of NO863061D0 publication Critical patent/NO863061D0/no

1987-02-02 Publication of NO863061L publication Critical patent/NO863061L/no

1992-07-13 Publication of NO170480B publication Critical patent/NO170480B/no

1992-10-21 Publication of NO170480C publication Critical patent/NO170480C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Child & Adolescent Psychology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fodder In General (AREA)

NO863061A 1985-07-30 1986-07-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater NO170480C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB858519154A GB8519154D0 (en)	1985-07-30	1985-07-30	Aromatic ethers

Publications (4)

Publication Number	Publication Date
NO863061D0 NO863061D0 (no)	1986-07-29
NO863061L NO863061L (no)	1987-02-02
NO170480B NO170480B (no)	1992-07-13
NO170480C true NO170480C (no)	1992-10-21

Family

ID=10583042

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO863061A NO170480C (no)	1985-07-30	1986-07-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater

Country Status (27)

Country	Link
US (1)	US4772631A (da)
EP (1)	EP0210849B1 (da)
JP (2)	JPH0651661B2 (da)
KR (1)	KR870001142A (da)
CN (1)	CN1014516B (da)
AR (1)	AR242176A1 (da)
AT (1)	ATE55980T1 (da)
AU (1)	AU603987B2 (da)
CA (1)	CA1283122C (da)
CS (1)	CS266593B2 (da)
DD (1)	DD251551A5 (da)
DE (1)	DE3673722D1 (da)
DK (1)	DK168761B1 (da)
ES (1)	ES2002720A6 (da)
FI (1)	FI88030C (da)
GB (1)	GB8519154D0 (da)
GR (1)	GR861994B (da)
HU (1)	HUT44757A (da)
IE (1)	IE60157B1 (da)
IL (1)	IL79447A0 (da)
NO (1)	NO170480C (da)
NZ (1)	NZ217011A (da)
PH (1)	PH22503A (da)
PL (1)	PL152320B1 (da)
PT (1)	PT83085B (da)
SU (1)	SU1632370A3 (da)
ZA (1)	ZA865097B (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3866984D1 (en) *	1987-07-21	1992-01-30	Hoffmann La Roche	Phenoxypropanolamine.
GB8801306D0 (en) *	1988-01-21	1988-02-17	Ici Plc	Chemical compounds
GB8905336D0 (en) *	1989-03-08	1989-04-19	Ici Plc	Chemical compounds
GB8910374D0 (en) *	1989-05-05	1989-06-21	Ici Plc	Chemical compounds
KR920005952B1 (ko) *	1989-05-26	1992-07-25	이사무 이와이	오수정화조의 여과재 순환 정화장치
GB8925032D0 (en) *	1989-11-06	1989-12-28	Ici Plc	Chemical compounds
GB8926083D0 (en) *	1989-11-17	1990-01-10	Ici Plc	Therapeutic agents
GB9003185D0 (en) *	1990-02-13	1990-04-11	Ici Plc	Pharmaceutical compositions
US5106867A (en) *	1990-05-04	1992-04-21	American Cyanamid Company	Method of increasing lean meat in edible animals
US5061727A (en)	1990-05-04	1991-10-29	American Cyanamid Company	Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5151439A (en) *	1990-05-04	1992-09-29	American Cyanamid Company	Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5245053A (en) *	1990-05-04	1993-09-14	American Cyanamid Company	Substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles
GB9016655D0 (en) *	1990-07-30	1990-09-12	Ici Plc	Therapeutic agents
US5502078A (en) *	1991-05-28	1996-03-26	Zeneca Limited	Chemical compounds
GB9111426D0 (en) *	1991-05-28	1991-07-17	Ici Plc	Chemical compounds
GB9111425D0 (en) *	1991-05-28	1991-07-17	Ici Plc	Chemical compounds
GB9224740D0 (en) *	1992-11-26	1993-01-13	Ici Plc	Therapeutic agents
US5578638A (en) *	1993-11-05	1996-11-26	American Cyanamid Company	Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) *	1993-11-05	1996-10-08	American Cyanamid Company	Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5776983A (en) *	1993-12-21	1998-07-07	Bristol-Myers Squibb Company	Catecholamine surrogates useful as β3 agonists
US5488064A (en) *	1994-05-02	1996-01-30	Bristol-Myers Squibb Company	Benzo 1,3 dioxole derivatives
US5491134A (en) *	1994-09-16	1996-02-13	Bristol-Myers Squibb Company	Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
US5541204A (en) *	1994-12-02	1996-07-30	Bristol-Myers Squibb Company	Aryloxypropanolamine β 3 adrenergic agonists
US6075040A (en) *	1996-09-05	2000-06-13	Eli Lilly And Company	Selective β3 adrenergic agonists
ZA967892B (en) *	1995-09-21	1998-03-18	Lilly Co Eli	Selective β3 adrenergic agonists.
US5770615A (en) *	1996-04-04	1998-06-23	Bristol-Myers Squibb Company	Catecholamine surrogates useful as β3 agonists
ATE215369T1 (de) *	1996-09-05	2002-04-15	Lilly Co Eli	Carbazolanaloge als selektive beta3-adrenergische agonisten
CO5011072A1 (es) *	1997-12-05	2001-02-28	Lilly Co Eli	Etanolaminas pirazinil substituidas como agfonistas de los receptores
GB9812709D0 (en) *	1998-06-13	1998-08-12	Glaxo Group Ltd	Chemical compounds
US6344481B1 (en)	1999-03-01	2002-02-05	Pfizer Inc.	Thyromimetic antiobesity agents
GB0102407D0 (en)	2001-01-31	2001-03-14	Glaxo Group Ltd	Process
US7709677B2 (en) *	2001-01-31	2010-05-04	Glaxosmithkline Llc	Process of preparing arylethanoldiamines
US7504435B2 (en) *	2001-01-31	2009-03-17	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Method for stimulating weight loss and/or for lowering triglycerides in patients
US7202222B2 (en) *	2003-01-06	2007-04-10	National Bioscience Corporation	Methods for treatment of obesity and effective fat loss promotion
MX2009009171A (es) *	2007-02-27	2010-03-04	Univ Arizona State	Administracion de acido 3,5-diyodotiropropionico para estimular perdida de peso y/o disminuir niveles de trigliceridos y/o para tratar sindrome metabolico.
US9044606B2 (en)	2010-01-22	2015-06-02	Ethicon Endo-Surgery, Inc.	Methods and devices for activating brown adipose tissue using electrical energy
US8476227B2 (en)	2010-01-22	2013-07-02	Ethicon Endo-Surgery, Inc.	Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9907767B2 (en)	2010-08-03	2018-03-06	Velicept Therapeutics, Inc.	Pharmaceutical compositions and the treatment of overactive bladder
US9522129B2 (en)	2010-08-03	2016-12-20	Velicept Therapeutics, Inc.	Pharmaceutical Combination
EP2819993B1 (en) *	2012-03-01	2020-09-02	University Of Cincinnati	Ros-activated compounds as selective anti-cancer therapeutics
EP3226849A4 (en)	2014-12-03	2018-05-09	Velicept Therapeutics, Inc.	Compositions and methods of using modified release solabegron for lower urinary tract symptoms
US10080884B2 (en)	2014-12-29	2018-09-25	Ethicon Llc	Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en)	2014-12-29	2018-10-09	Ethicon Llc	Methods and devices for inhibiting nerves when activating brown adipose tissue
CN114230477A (zh)	2015-10-23	2022-03-25	B3Ar治疗股份有限公司	索拉贝隆两性离子及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1245148A (en) *	1968-11-18	1971-09-08	Pfizer Ltd	Propanolamine derivatives
CA957364A (en) *	1968-11-18	1974-11-05	Pfizer Corporation	Preparation of polar-substituted phenyl propanolamines
SE354851B (da) *	1970-02-18	1973-03-26	Haessle Ab
US4146638A (en) *	1976-02-17	1979-03-27	Boehringer Ingelheim Gmbh	N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) *	1976-05-25	1980-03-04	Hoechst Aktiengesellschaft	1-Aryloxy-2-hydroxy-3-aminopropanes
SE416545B (sv) *	1976-10-07	1981-01-19	Haessle Ab	Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat
CH632987A5 (en) *	1976-10-07	1982-11-15	Haessle Ab	Process for preparing novel amines
EP0006735B1 (en) *	1978-06-28	1983-06-15	Beecham Group Plc	Secondary amines, their preparation, pharmaceutical compositions containing them and their use
SE7807408L (sv) *	1978-06-30	1979-12-31	Haessle Ab	Hjertaktiva foreningar
DE3061334D1 (en) *	1979-06-16	1983-01-20	Beecham Group Plc	Ethanamine derivatives, their preparation and use in pharmaceutical compositions
EP0028105B1 (en) *	1979-10-25	1983-01-19	Beecham Group Plc	Secondary amines, their preparation and use in pharmaceutical compositions
IL65541A0 (en) *	1981-05-06	1982-07-30	Haessle Ab	Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same
GB8415377D0 (en) *	1984-06-15	1984-07-18	Beecham Group Plc	Compounds
GB8510146D0 (en) *	1985-04-20	1985-05-30	Smith Kline French Lab	Chemical compounds & processes

1985
- 1985-07-30 GB GB858519154A patent/GB8519154D0/en active Pending
1986
- 1986-07-07 IE IE182786A patent/IE60157B1/en not_active IP Right Cessation
- 1986-07-08 ZA ZA865097A patent/ZA865097B/xx unknown
- 1986-07-09 PH PH33996A patent/PH22503A/en unknown
- 1986-07-09 FI FI862896A patent/FI88030C/fi not_active IP Right Cessation
- 1986-07-10 AU AU60029/86A patent/AU603987B2/en not_active Ceased
- 1986-07-17 IL IL79447A patent/IL79447A0/xx not_active IP Right Cessation
- 1986-07-23 PL PL1986260759A patent/PL152320B1/pl unknown
- 1986-07-25 DE DE8686305749T patent/DE3673722D1/de not_active Expired - Lifetime
- 1986-07-25 AT AT86305749T patent/ATE55980T1/de not_active IP Right Cessation
- 1986-07-25 EP EP86305749A patent/EP0210849B1/en not_active Expired - Lifetime
- 1986-07-28 HU HU863206A patent/HUT44757A/hu unknown
- 1986-07-28 US US06/889,857 patent/US4772631A/en not_active Expired - Lifetime
- 1986-07-29 DK DK359986A patent/DK168761B1/da not_active IP Right Cessation
- 1986-07-29 PT PT83085A patent/PT83085B/pt unknown
- 1986-07-29 NZ NZ217011A patent/NZ217011A/en unknown
- 1986-07-29 NO NO863061A patent/NO170480C/no unknown
- 1986-07-29 DD DD86293056A patent/DD251551A5/de not_active IP Right Cessation
- 1986-07-29 SU SU864027877A patent/SU1632370A3/ru active
- 1986-07-29 GR GR861994A patent/GR861994B/el unknown
- 1986-07-29 CA CA000514820A patent/CA1283122C/en not_active Expired - Lifetime
- 1986-07-30 AR AR86304733A patent/AR242176A1/es active
- 1986-07-30 CN CN86105400A patent/CN1014516B/zh not_active Expired
- 1986-07-30 CS CS865735A patent/CS266593B2/cs unknown
- 1986-07-30 JP JP61177914A patent/JPH0651661B2/ja not_active Expired - Lifetime
- 1986-07-30 ES ES8600729A patent/ES2002720A6/es not_active Expired
- 1986-07-30 KR KR1019860006278A patent/KR870001142A/ko not_active Application Discontinuation
1993
- 1993-12-24 JP JP5327984A patent/JPH0819062B2/ja not_active Ceased

Also Published As

Publication number	Publication date
AU6002986A (en)	1987-02-05
IE60157B1 (en)	1994-06-15
DD251551A5 (de)	1987-11-18
ZA865097B (en)	1987-03-25
NO863061L (no)	1987-02-02
PL260759A1 (en)	1988-09-15
NO170480B (no)	1992-07-13
DK359986D0 (da)	1986-07-29
DK168761B1 (da)	1994-06-06
CA1283122C (en)	1991-04-16
EP0210849B1 (en)	1990-08-29
DE3673722D1 (en)	1990-10-04
CN86105400A (zh)	1987-03-11
FI88030B (fi)	1992-12-15
JPS6277357A (ja)	1987-04-09
ES2002720A6 (es)	1988-10-01
CS266593B2 (en)	1990-01-12
DK359986A (da)	1987-01-31
EP0210849A1 (en)	1987-02-04
NZ217011A (en)	1990-02-26
CS573586A2 (en)	1989-04-14
IL79447A0 (en)	1986-10-31
KR870001142A (ko)	1987-03-11
FI862896A0 (fi)	1986-07-09
JPH0651661B2 (ja)	1994-07-06
PT83085B (pt)	1989-01-30
US4772631A (en)	1988-09-20
CN1014516B (zh)	1991-10-30
FI862896A (fi)	1987-01-31
SU1632370A3 (ru)	1991-02-28
IE861827L (en)	1987-01-30
PT83085A (en)	1986-08-01
JPH06340597A (ja)	1994-12-13
ATE55980T1 (de)	1990-09-15
AU603987B2 (en)	1990-12-06
HUT44757A (en)	1988-04-28
JPH0819062B2 (ja)	1996-02-28
PL152320B1 (en)	1990-12-31
AR242176A1 (es)	1993-03-31
PH22503A (en)	1988-09-12
GR861994B (en)	1986-11-26
FI88030C (fi)	1993-03-25
NO863061D0 (no)	1986-07-29
GB8519154D0 (en)	1985-09-04

Publication	Publication Date	Title
NO170480C (no)	1992-10-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater
NO864425L (no)	1987-05-08	Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater
NO172343C (no)	1993-07-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater
NO169493C (no)	1992-07-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive peptid-derivater
NO168770C (no)	1992-04-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO163406C (no)	1990-05-23	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO864126D0 (no)	1986-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO862477D0 (no)	1986-06-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO170629C (no)	1992-11-11	Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO171638C (no)	1993-04-14	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater
NO167916C (no)	1991-12-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
NO167026C (no)	1991-09-25	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO865204D0 (no)	1986-12-19	Fremgangsmaate for fremstilling av terapeutisk aktive benzoesyre- og benzoesyreester-derivater.
NO169014C (no)	1992-04-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive distamycinderivater
NO168355C (no)	1992-02-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO170976C (no)	1993-01-06	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater
NO170482C (no)	1992-10-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater
NO162619C (no)	1990-01-24	Analogifremgangsmaate for fremstilling av terapeutisk aktive l-aminosyre-derivater
NO168299C (no)	1992-02-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO171592C (no)	1993-04-07	Fremgangsmaate for fremstilling av aktive cinnolin-derivater
NO164982C (no)	1990-12-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO862372D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO169069C (no)	1992-05-06	Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO169648C (no)	1992-07-22	Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
NO171108C (no)	1993-01-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater